Brock Metcalf
Founder at Reference Capital Management LLC
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Gilbert N. Miller | M | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR.
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 23 years |
James Hicks | M | 77 |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 years |
Peter C. M. McWilliams | M | - |
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | - |
Jeff King | M | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 years |
Renee Shirley | F | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | 23 years |
Halina Offner | M | - |
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 20 years |
Arthur A. Vandenbark | M | - |
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 20 years |
Wayne L. Embree | M | - |
Reference Capital Management LLC
Reference Capital Management LLC Investment ManagersFinance Reference Capital Management LLC (Reference Capital) is a venture capital firm founded in 2006 by Wayne L. Embree and Brock Metcalf. The firm is headquartered in Portland, Oregon. | 38 years |
James W. Korfhage | M | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
David C.E Williams | M | - |
Reference Capital Management LLC
Reference Capital Management LLC Investment ManagersFinance Reference Capital Management LLC (Reference Capital) is a venture capital firm founded in 2006 by Wayne L. Embree and Brock Metcalf. The firm is headquartered in Portland, Oregon. | 13 years |
Rob Wiltbank | M | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
Shahab Fatheazam | M | 72 |
Artielle ImmunoTherapeutics, Inc.
Artielle ImmunoTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Artielle ImmunoTherapeutics, Inc. develops therapeutics for autoimmune diseases. Its Recombinant T-cell receptor Ligands can be tailored to target different illnesses. The company develops RTL1000, a compound for the treatment of multiple sclerosis. The company was founded by Halina Offner, Arthur Vandenbark and Gregory G. Burrows in 2004 and is headquartered in San Mateo, CA. | 20 years |
William Newman | M | - |
Virogenomics BioDevelopment, Inc.
Virogenomics BioDevelopment, Inc. BiotechnologyHealth Technology Virogenomics BioDevelopment, Inc. develops new drugs for the treatment of human diseases. Its business strategy is to identify and obtain rights to early-stage technologies, manage and develop these technologies to a critical phase, and then spin-off the developed technologies into new start-up companies. The company was founded by Jeffrey King and Renee Shirley in 2001 and is headquartered in Portland, OR. | - |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Daniel Mauney | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Trey Snow | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Lisa Marie Roberts | F | 57 |
Virginia Polytechnic Institute & State University
| 6 years |
Robert Goetz | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Christopher Baker | M | - |
Virginia Polytechnic Institute & State University
| 3 years |
David Meier | M | - |
Virginia Polytechnic Institute & State University
| 7 years |
Noel Heiks | F | 53 |
Virginia Polytechnic Institute & State University
| 9 years |
Steve Fredrick | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Charles D. Johnson | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Bryan Tinsley | M | - |
Virginia Polytechnic Institute & State University
| 6 years |
Jian-Zhong Qian | M | 76 |
Virginia Polytechnic Institute & State University
| 5 years |
Paul S. Kramer | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Charles Walker Dorroh | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Robert Taylor | M | - |
Virginia Polytechnic Institute & State University
| 10 years |
David J. Sturek | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Howard N. Shipley | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Christopher L. Symanoskie | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Jay Parikh | M | 51 |
Virginia Polytechnic Institute & State University
| 4 years |
Matt Fleming | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Uma Jayaram | M | - |
Virginia Polytechnic Institute & State University
| 3 years |
Kelley Williamson | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Gregory Stanton Kaplan | M | - |
Virginia Polytechnic Institute & State University
| 2 years |
Jill Zelter | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Ken Lanford | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Kord J. Wissman | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
James D. Ross | M | 75 |
Virginia Polytechnic Institute & State University
| 4 years |
Robert Reed | M | 59 |
Virginia Polytechnic Institute & State University
| 4 years |
Johny Tjoa | M | - |
Virginia Polytechnic Institute & State University
| 2 years |
Burke Jason | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Mark Newton | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Liang Qiang | M | 59 |
Virginia Polytechnic Institute & State University
| 6 years |
Nicole Vipperman | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Michael C. Brown | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Chip Devine | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Hal Frankel | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Christopher Thomas | M | - |
Virginia Polytechnic Institute & State University
| 10 years |
Geoffrey Grammer | M | 53 |
Virginia Polytechnic Institute & State University
| 4 years |
James Michael Shapaker | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Edward Baron | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Paul Evangel Petera | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Todd Meredith | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Jennifer Mertz | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Carla R. Stoner | F | 62 |
Virginia Polytechnic Institute & State University
| 4 years |
Denise C. Whennen | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Chris Massey | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
John F. Naber | M | - |
Virginia Polytechnic Institute & State University
| 3 years |
Norman Adkins | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Jonathan Ebinger | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Robert L. Gunter | M | - |
Virginia Polytechnic Institute & State University
| 2 years |
Keith A. Whitener | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Russell Thomas | M | 61 |
Virginia Polytechnic Institute & State University
| 4 years |
Stephanie Reese | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Brian Callaghan | M | 53 |
Virginia Polytechnic Institute & State University
| 4 years |
Ashraf Lotfi | M | 63 |
Virginia Polytechnic Institute & State University
| 3 years |
Raman Khanna | M | - |
Virginia Polytechnic Institute & State University
| 1 years |
Ian Patrick Sobieski | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
P. Christopher Holland | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Barbara A. Murphy | F | 86 |
Virginia Polytechnic Institute & State University
| 4 years |
Mark Peter Roemer | M | 60 |
Virginia Polytechnic Institute & State University
| 5 years |
Jeff Wlodarczak | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Michael Cole | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Edwin Sheridan | M | 54 |
Virginia Polytechnic Institute & State University
| 4 years |
Bryan D. Smith | M | 54 |
Virginia Polytechnic Institute & State University
| 4 years |
Gregory Thomas | M | 58 |
Virginia Polytechnic Institute & State University
| 4 years |
Christopher W. Shean | M | 58 |
Virginia Polytechnic Institute & State University
| 4 years |
Michael Glasgow | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
J. David Craig | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Scott Harlan | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Rachel Chiang | F | 56 |
Virginia Polytechnic Institute & State University
| 4 years |
James Bright | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
A. Leigh Powell | M | 61 |
Virginia Polytechnic Institute & State University
| 2 years |
Graham Stead | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Andrew W. Whipple | M | 60 |
Virginia Polytechnic Institute & State University
| 4 years |
Craig Edward Barker | M | 63 |
Virginia Polytechnic Institute & State University
| 1 years |
Jeff Phillips | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
William Brewster | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Michael Natchus | M | - |
Virginia Polytechnic Institute & State University
| 3 years |
Thomas L. Payne | M | - |
Virginia Polytechnic Institute & State University
| - |
M. Shane Harvey | M | 54 |
Virginia Polytechnic Institute & State University
| 4 years |
Lisa Healy | F | - |
Virginia Polytechnic Institute & State University
| 4 years |
Sid Adkins | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Wm Braun Jones | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Michael R. Bedsaul | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
William N. Colonna | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Scott Fletcher | M | - |
Virginia Polytechnic Institute & State University
| 4 years |
Mike A. Hincher | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Bill Roller | M | - |
Virginia Polytechnic Institute & State University
| 5 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Brock Metcalf
- Personal Network